Identification of tipifarnib sensitivity biomarkers in T-cell acute lymphoblastic leukemia and T-cell lymphoma

Patients diagnosed with T-cell leukemias and T-cell lymphomas (TCLs) still have a poor prognosis and an inadequate response to current therapies, highlighting the need for targeted treatments. We have analyzed the potential therapeutic value of the farnesyltransferase inhibitor, tipifarnib, in 25 TC...

Descripción completa

Detalles Bibliográficos
Autores principales: Alonso-Alonso, Ruth, Mondéjar, Rufino, Martínez, Nerea, García-Diaz, Nuria, Pérez, Cristina, Merino, David, Rodríguez, Marta, Esteve-Codina, Anna, Fuste, Berta, Gut, Marta, Burrows, Francis, Scholz, Catherine, Vaqué, Jose Pedro, Gualberto, Antonio, Piris, Miguel Ángel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174413/
https://www.ncbi.nlm.nih.gov/pubmed/32317694
http://dx.doi.org/10.1038/s41598-020-63434-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174413/
https://www.ncbi.nlm.nih.gov/pubmed/32317694
http://dx.doi.org/10.1038/s41598-020-63434-5

Ejemplares similares